Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Carson W. Ercanbrack's research primarily investigates ocular conditions and their treatment, with a focus on visual outcomes and disease mechanisms. Recent publications include studies on the regression of retinal capillary hemangioblastoma, the utility of PCR in endophthalmitis, and visual outcomes in traumatic aphakia. Ercanbrack also has work related to periocular reconstructive surgery and the identification of mistranslation in living cells. Collaborations include shared publications with Sami H. Uwaydat, Sayena Jabbehdari, Muhammad Z. Chauhan, and Jamal O. Azhari, all from the University of Arkansas for Medical Sciences. Ercanbrack's scholarship metrics include an h-index of 3, with 9 total publications and 54 citations.
Metrics
- h-index: 3
- Publications: 11
- Citations: 56
Selected Publications
-
Visual Outcomes in Traumatic Aphakia Corrected with Contact Lens versus Intraocular Lens Implantation – A Retrospective Chart Review (2026)
-
Unmasking Primary Immunodeficiency After Rituximab (2026)
-
Update and review of the current medical and surgical management of sickle cell retinopathy (2026)
-
Association between retinal findings and risk of mortality in pediatric abusive head trauma (2026)
-
Updates on periocular post-Mohs reconstructive surgery: a clinical practice review (2025)
-
Early Optical Coherence Tomography Signs of Erdafitinib-Induced Retinopathy (2024)
-
Utility of pan-bacterial and pan-fungal PCR in endophthalmitis: case report and review of the literature (2024)
-
Maculopathy in a 52-Year-Old Patient With Diabetes (2024)
-
Belzutifan-induced regression of retinal capillary hemangioblastoma: A case-series (2024)
-
Unusual Pediatric Red Eye (2024)
-
Total Therapy (TT)-4: A Phase 3 Trial Comparing L-TT4 and S-TT4 and Tandem Auto Transplants in Standard Risk Multiple Myeloma (2023)
-
Genome-Wide Screening of Oxidizing Agent Resistance Genes in Escherichia coli (2021)
-
A Synthetic Reporter for Probing Mistranslation in Living Cells (2020)
Collaboration Network
Top Collaborators
- Belzutifan-induced regression of retinal capillary hemangioblastoma: A case-series
- Utility of pan-bacterial and pan-fungal PCR in endophthalmitis: case report and review of the literature
- Maculopathy in a 52-Year-Old Patient With Diabetes
- Early Optical Coherence Tomography Signs of Erdafitinib-Induced Retinopathy
- Visual Outcomes in Traumatic Aphakia Corrected with Contact Lens versus Intraocular Lens Implantation – A Retrospective Chart Review
- Genome-Wide Screening of Oxidizing Agent Resistance Genes in Escherichia coli
- A Synthetic Reporter for Probing Mistranslation in Living Cells
- Genome-Wide Screening of Oxidizing Agent Resistance Genes in Escherichia coli
- A Synthetic Reporter for Probing Mistranslation in Living Cells
- Belzutifan-induced regression of retinal capillary hemangioblastoma: A case-series
- Unusual Pediatric Red Eye
- Maculopathy in a 52-Year-Old Patient With Diabetes
- Early Optical Coherence Tomography Signs of Erdafitinib-Induced Retinopathy
- Utility of pan-bacterial and pan-fungal PCR in endophthalmitis: case report and review of the literature
- Early Optical Coherence Tomography Signs of Erdafitinib-Induced Retinopathy
- A Synthetic Reporter for Probing Mistranslation in Living Cells
- A Synthetic Reporter for Probing Mistranslation in Living Cells
- Genome-Wide Screening of Oxidizing Agent Resistance Genes in Escherichia coli
- Genome-Wide Screening of Oxidizing Agent Resistance Genes in Escherichia coli
- Genome-Wide Screening of Oxidizing Agent Resistance Genes in Escherichia coli
- Total Therapy (TT)-4: A Phase 3 Trial Comparing L-TT4 and S-TT4 and Tandem Auto Transplants in Standard Risk Multiple Myeloma
- Total Therapy (TT)-4: A Phase 3 Trial Comparing L-TT4 and S-TT4 and Tandem Auto Transplants in Standard Risk Multiple Myeloma
- Total Therapy (TT)-4: A Phase 3 Trial Comparing L-TT4 and S-TT4 and Tandem Auto Transplants in Standard Risk Multiple Myeloma
- Total Therapy (TT)-4: A Phase 3 Trial Comparing L-TT4 and S-TT4 and Tandem Auto Transplants in Standard Risk Multiple Myeloma
Similar Researchers
Based on overlapping research topics